Cite
HARVARD Citation
Lucidarme, C. et al. (2019). Predictors of relapse following infliximab de‐escalation in patients with inflammatory bowel disease: the value of a strategy based on therapeutic drug monitoring. Alimentary pharmacology & therapeutics. 49 (2), pp. 147-154. [Online].